MyCartis. Unlocking answers in immunodiagnostics.
MyCartis is an immunoassay company, aiming to provide robust solutions to make it possible running fast and highly sensitive assays in order to assess the patient’s biomarker signature. To this end, MyCartis developed an innovative, unique and proprietary platform called Evalution™, enabling to assess patients’ immune system responses by providing precise and personalized novel clinical information for the benefit of researchers and clinicians.
Included in the Export Interest Directory? No
Business Needs: Investor, Other